C3’s Countdown to the New Year

In 2022, C3 …

• Announced 5 new research projects
• Generated 4 novel mouse models for preclinical drug testing
• Co-organized an EL-PFDD meeting where 300+ individuals with LGMD tuned in to share their perspectives on what it is like to live with this disease and what they hope to gain from future treatments
• Raised over $50,000 for gene therapy research thanks to many generous donors, including one family who provided a 2X match on Giving Tuesday
• Dedicated to 1 singular focus: to drive research towards a cure for LGMD2A/R1

BE A C3 CHAMPION AND MAKE A YEAR-END CONTRIBUTION TO ADVANCE TREATMENTS FOR FAMILIES IMPACTED BY LGMD2A/R1